Education
About Us
Working with TipRanks
Follow Us
Medartis Holding AG (CH:MED)
:MED
MED Stock Chart & Stats
Day’s Range― - ―
52-Week RangeCHF44.15 - CHF82.00
Previous CloseN/A
Volume945.00
Average Volume (3M)5.77K
Market Cap
CHF999.28M
Enterprise ValueCHF920.93M
Total Cash (Recent Filing)CHF99.57M
Total Debt (Recent Filing)CHF26.43M
Price to Earnings (P/E)278.3
Beta1.29
Next Earnings
Aug 19, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.27
Shares Outstanding13,595,704
10 Day Avg. Volume4,283
30 Day Avg. Volume5,769
Financial Highlights & Ratios
PEG Ratio0.62
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
CHF86.00Price Target Upside17.65% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Medartis Holding AG News
---
Bulls Say, Bears Say
Bulls Say
Acquisition StrategyThe acquisition of a 51% stake in NeoOrtho is viewed favorably, providing a multi-tiered product approach in the Brazilian market.
Product LaunchThere is an expectation that the TOUCH prothesis product launch will contribute to growth in 2025, based on positive surgeon feedback.
Strategic FocusMore focus on Upper Extremities going forward, where the portfolio is complete, and the Keri Touch thumb device can generate pull-through, is seen as the right approach.
Bears Say
Market ExpectationsTop-line FY25 guidance is approximately 7-9% below consensus, which is causing disappointment despite EBITDA being in line.
Operational IssuesManagement referred to issues surrounding client engagement/onboarding, set retrieval/line filling, and management changes and unachievable targets in the U.S.
US Market ChallengesThe US market is undergoing a strategic review, with 2024 being a transition year, and growth in this region is key to future success.
---
Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.95%
Mutual Funds
― Other Institutional Investors
98.22% Public Companies and
Individual Investors
MED FAQ
What was Medartis Holding AG’s price range in the past 12 months?
Medartis Holding AG lowest stock price was CHF44.15 and its highest was CHF82.00 in the past 12 months.
What is Medartis Holding AG’s market cap?
Medartis Holding AG’s market cap is CHF999.28M.
When is Medartis Holding AG’s upcoming earnings report date?
Medartis Holding AG’s upcoming earnings report date is Aug 19, 2025 which is in 123 days.
How were Medartis Holding AG’s earnings last quarter?
Medartis Holding AG released its earnings results on Mar 18, 2025. The company reported CHF0.078 earnings per share for the quarter, beating the consensus estimate of N/A by CHF0.078.
Is Medartis Holding AG overvalued?
According to Wall Street analysts Medartis Holding AG’s price is currently Undervalued.
Does Medartis Holding AG pay dividends?
Medartis Holding AG does not currently pay dividends.
What is Medartis Holding AG’s EPS estimate?
Medartis Holding AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Medartis Holding AG have?
Medartis Holding AG has 13,595,704 shares outstanding.
What happened to Medartis Holding AG’s price movement after its last earnings report?
Medartis Holding AG reported an EPS of CHF0.078 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 3.262%.
Which hedge fund is a major shareholder of Medartis Holding AG?
Currently, no hedge funds are holding shares in CH:MED
---
MED Stock 12 Month Forecast
Average Price Target
CHF86.00
▲(17.65% Upside)
Technical Analysis
Lonza Group Ltd
―
Straumann Holding AG
―
Medacta Group SA
―
Tecan Group AG
―
Ypsomed Holding AG
―
Best Analysts Covering MED
1 Year
1 Year Success Rate
1/1 ratings generated profit
1 Year Average Return
+0.10%
reiterated a buy rating 25 days ago
Copying Dylan Van Haaften's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +0.10% per trade.
---